<DOC>
	<DOCNO>NCT00863213</DOCNO>
	<brief_summary>The purpose study compare effectivity safety atrial fibrillation ablation , comparison antiarrhythmic drug therapy patient refractory , persistent atrial fibrillation .</brief_summary>
	<brief_title>Study Ablation Versus antiaRrhythmic Drugs Persistent Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Patients persistent atrial fibrillation ( 7 day , le 7 day need pharmacologic electric cardioversion ) Hypo hyperthyroidism Persistent atrial fibrillation last 1 year nondefined duration Hypertrophic myocardiopathy Implantable defibrillation pacemaker implant Moderate severe mitral valve disease mitral prosthetic valve Ejection fraction le 30 % Left atrial anteroposterior diameter 50 mm . Previous atrial fibrillation ablation Contraindication anticoagulation Left atrium thrombus Current infective disease sepsis Pregnant woman Current unstable angor Acute myocardial infarction last 3 month Atrial fibrillation secondary ionic disturbance , thyroid disease secondary reversible non cardiovascular disease Reduced expectancy life ( le 12 month ) Patient participate another clinical study investigate drug device Psychologically unstable patient denies give informed consent Any cause contraindicate ablation procedure antiarrhythmic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Catheter Ablation , Radiofrequency</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Antiarrhythmic Drugs</keyword>
</DOC>